A Phase IIIb, Prospective, Multicentre, Open-Label Extension Study To Assess Long Term Safety And Effectiveness Of Dysport Using 2 mL Dilution In Adults With Cervical Dystonia
Phase of Trial: Phase III
Latest Information Update: 09 May 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Sponsors Ipsen
- 21 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 29 Jun 2015 Planned End Date changed from 1 Nov 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
- 29 Jun 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.